Artelo Biosciences, Inc. (ARTL)

CIK 1621221 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Artelo Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
Aug 27, 20268-K0001640334-26-001421
Aug 20, 202610-Q/A0001640334-26-001400
Aug 14, 2026SCHEDULE 13G/A0001172661-26-003551
Aug 13, 2026SCHEDULE 13G/A0001213900-26-088826
Aug 12, 202610-Q0001640334-26-001323
Jul 21, 202640001640334-26-001221
Jul 21, 202640001640334-26-001227
Jul 21, 202640001640334-26-001225
Jul 21, 202640001640334-26-001223
Jul 21, 202640001640334-26-001229
Jul 21, 202640001640334-26-001231
Jul 17, 20268-K0001640334-26-001198
Jul 16, 2026DEFA14A0001640334-26-001186
Jul 16, 2026DEFA14A0001640334-26-001189
Jul 2, 2026DEFA14A0001640334-26-001147
Jun 22, 2026PRER14A0001640334-26-001106
Jun 5, 2026DEFA14A0001640334-26-001009
Jun 5, 2026ARS0001640334-26-001011
Jun 5, 2026DEF 14A0001640334-26-001007
May 27, 20268-K0001640334-26-000973
May 26, 2026424B50001640334-26-000966
May 26, 2026PRE 14A0001640334-26-000969
May 19, 2026EFFECT9999999995-26-001705
May 18, 2026424B50001640334-26-000926
May 15, 20268-K0001640334-26-000903